Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia
Open Access
- 20 February 2003
- Vol. 97 (5) , 1248-1252
- https://doi.org/10.1002/cncr.11217
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Telomerase and Telomeres: From Basic Biology to Cancer TreatmentCancer Investigation, 2002
- Telomerase inhibitors for the treatment of cancer: the current perspectiveExpert Opinion on Investigational Drugs, 2001
- Complex Regulation of Telomerase Activity: Implications for Cancer TherapyThe American Journal of Pathology, 2001
- Highly Reproducible Detection and Semi-Quantification of Telomerase ActivityBioTechniques, 2001
- Telomere Dynamics and Genetic Instability in Disease Progression of Chronic Myeloid LeukemiaLeukemia & Lymphoma, 2000
- Telomere length shortening is associated with disease evolution in chronic myelogenous leukemiaAmerican Journal of Hematology, 1999
- Subsequential Alterations of Telomeric DNA Length Correlate with Cytogenetic Response in Chronic Myeloid Leukemia Treated with Interferon alphaHematology, 1999
- Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progressionLeukemia, 1997
- Telomerase activity in normal and malignant hematopoietic cells.Proceedings of the National Academy of Sciences, 1995
- Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemiaThe American Journal of Medicine, 1990